Australia - English - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - oxycodone hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - oxycodone hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - morphine sulfate -

Australia - English - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - naloxone hydrochloride; oxycodone hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - timolol maleate, quantity: 3.42 mg/ml (equivalent: timolol, qty 2.5 mg/ml) - eye drops, solution - excipient ingredients: benzalkonium chloride; monobasic sodium phosphate; dibasic sodium phosphate dodecahydrate; water for injections; sodium hydroxide - timoptol ophthalmic solution is indicated for the reduction of elevated intraocular pressure. in clinical trials it has been shown to reduce intraocular pressure in: patients with ocular hypertension - patients with chronic open-angle glaucoma - aphakic patients with glaucoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: monobasic sodium phosphate; dibasic sodium phosphate dodecahydrate; sodium hydroxide; benzalkonium chloride; water for injections - timoptol ophthalmic solution is indicated for the reduction of elevated intraocular pressure. in clinical trials it has been shown to reduce intraocular pressure in: patients with ocular hypertension - patients with chronic open-angle glaucoma - aphakic patients with glaucoma.

New Zealand - English - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 10mg;  ;   - modified release tablet - 10 mg - active: oxycodone hydrochloride 10mg     excipient: ammonio methacrylate copolymer lactose monohydrate magnesium stearate opadry white y-5-18024-a povidone purified talc stearyl alcohol triacetin - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia

New Zealand - English - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 120mg - modified release tablet - 120 mg - active: oxycodone hydrochloride 120mg excipient: ammonio methacrylate copolymer lactose monohydrate magnesium stearate opadry purple 15b20201 povidone purified talc purified water stearyl alcohol triacetin - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia.

New Zealand - English - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 15mg equivalent to 13.5 mg oxycodone base - modified release tablet - 15 mg - active: oxycodone hydrochloride 15mg equivalent to 13.5 mg oxycodone base excipient: lactose monohydrate magnesium stearate methacrylic acid copolymer opadry grey 05b97512 povidone purified talc stearyl alcohol triacetin - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia

New Zealand - English - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 20mg;  ;   - modified release tablet - 20 mg - active: oxycodone hydrochloride 20mg     excipient: ammonio methacrylate copolymer lactose monohydrate magnesium stearate opadry pink ys-1-14518-a povidone purified talc stearyl alcohol triacetin - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia